A Comparison Between Culprit Versus Complete Revascularization in Diabetic Patients With Acute Myocardial Infarction
Open Access
- 14 November 2024
- journal article
- research article
- Published by Wiley in Clinical Cardiology
- Vol. 47 (11) , e70046
Abstract
Introduction: The benefit of complete revascularization in diabetic patients with myocardial infarction remains unclear. this study aims to find the optimal strategy of total vascular repair for diabetic patients with acute myocardial infarction.Methods: In an analysis of a cohort, we assigned diabetic patients with myocardial infarction who were undergoing percutaneous coronary intervention (PCI) of the culprit lesion to receive either staged complete revascularization of nonculprit lesions or to receive no further revascularization in Madani Hospital (Tabriz, Iran). Functionally significant nonculprit lesions were identified either by angiography. The primary outcome was rates of readmission, cardiac deaths, nonfatal myocardial re‐infarction, and overall mortality at 1 year.Results: In our center, a total of 1186 patients underwent primary‐PCI treatment, among which 521 were diagnosed with diabetes. Ultimately, 393 patients were selected for inclusion in the study. Within this cohort, 271 individuals (68.9%) underwent repair of only the culprit vessels (group 1), while 122 individuals (31.1%) received a comprehensive staged restoration of the vessels (group 2). During this time, group 1 in comparison with group 2 experienced 204 (75.3%) versus 97 (79.5%) cases of readmission, 48 (17.7%) versus 8 (6.5%) instances of cardiac death, 22 (8.1%) versus 18 (14.7%) occurrences of nonfatal myocardial re‐infarction. Notably, the incidence of cardiac death in group 2 were significantly lower than that in group 1 (p ≤ 0.05).Conclusions: For individuals diagnosed with diabetes, staged complete revascularization demonstrated a lower frequency of readmission, cardiac deaths, nonfatal myocardial reinfarction, and overall mortality, in contrast to revascularization that targeted only the culprit lesion.Keywords
This publication has 33 references indexed in Scilit:
- Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary SyndromesJACC, 2018
- The paradox of clopidogrel use in patients with acute coronary syndromes and diabetesCoronary Artery Disease, 2018
- Coronary Artery Disease in Patients ≥80 Years of AgeJACC, 2018
- Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD)American Heart Journal, 2018
- Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention – a report from SCAARBlood Pressure, 2017
- Does heart rate variability correlate with long-term prognosis in myocardial infarction patients treated by early revascularization?World Journal of Cardiology, 2017
- A Randomized Trial of Complete Versus Culprit‐Only Revascularization During Primary Percutaneous Coronary Intervention in Diabetic Patients With Acute ST Elevation Myocardial Infarction and Multi Vessel DiseaseJournal of Interventional Cardiology, 2016
- Knowledge Gaps in Cardiovascular Care of the Older Adult PopulationCirculation, 2016
- 2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial InfarctionJACC, 2016
- Extent, Location, and Clinical Significance of Non–Infarct-Related Coronary Artery Disease Among Patients With ST-Elevation Myocardial InfarctionJAMA, 2014